Challenges and opportunities for hepatitis C drug development in HIV–hepatitis C virus-co-infected patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Challenges and opportunities for hepatitis C drug development in HIV–hepatitis C virus-co-infected patients

Published:2011-11-28 Issue:18 Volume:25 Page:2197-2208
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Soriano Vincent,Sherman Kenneth E.,Rockstroh Juergen,Dieterich Douglas,Back David,Sulkowski Mark,Peters Marion

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference65 articles.

1. Liver-related deaths in persons infected with the HIV: the D:A:D study.;Weber;Arch Intern Med,2006

2. HIV infection and the liver: the importance of HCV-HIV coinfection and drug-induced liver injury.;Merwat;Clin Liver Dis,2011

3. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.;Soriano;AIDS,2007

4. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.;Rockstroh;HIV Med,2008

5. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.;Qurishi;Lancet,2003

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consequence of HIV and HCV co-infection on host immune response, persistence and current treatment options;VirusDisease;2018-01-27

2. HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study;HIV Clinical Trials;2017-05-04

3. Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy;HIV/AIDS - Research and Palliative Care;2015-12

4. New hepatitis C therapies for special patient populations;Expert Opinion on Pharmacotherapy;2015-11-23

5. Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects;Expert Opinion on Drug Safety;2015-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3